Wholesale of pharmaceutical and medical goods
DIAGEN AS
Revenue 2024
NOK 13.5m
Operating profit
NOK −3.6m
Equity
NOK 7.2m
Incorporated
2004
Employees
8
Share capital
NOK 100,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 13.5m | |
| Total operating costs | 17.1m | |
| Operating profit (EBIT) | −3.6m | |
| Net financial items | −4.4m | |
| Profit for the year | −8.0m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 26.2m | |
| of which current assets | 13.6m | |
| Equity | 7.2m | |
| Total liabilities | 19.0m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.